Sunbird Bio is a leader in protein-based diagnostic tests, becoming the first company to overcome the challenge of accurately detecting and differentiating the specific proteins that aggregate, and therefore signal the presence of Alzheimer’s disease, with a simple blood draw. We are addressing the tremendous, growing need for more reliable and sensitive diagnostic tests to accelerate drug development and enhance patient care.

Our pipeline of innovative, non-invasive technologies, such as our APEX technology, will empower researchers and clinicians with unparalleled insights not available from current tests. 

Biotechnology

Health Diagnostics

Life Sciences

Sunbird Bio

Sangeeta Bhatia

Raynie Smith

Matthew Navarro

Mario Morken

Christopher Gulka

Brian Minie

The Scientific Research and Development team at Sunbird Bio focuses on pioneering advanced diagnostic technologies, including the APEX platform, for the accurate detection of proteins indicative of Alzheimer's disease. Comprising members like the Scientist II in Synthesis & Discovery, Principal Scientist, Research Scientist, and Associate Scientist, this team drives innovation through rigorous research, synthesis of novel biomarkers, and development of non-invasive testing methods to support enhanced patient care and expedite drug development.

Scientific Research and Development

Leadership Team

Scientific Research and Development

About

Team members

Other teams at Sunbird Bio

Leadership Team